Why I’d buy these 2 rising FTSE 100 shares

More capital gains could lie ahead for these two FTSE 100 (INDEXFTSE:UKX) stocks.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

While the FTSE 100’s price level has risen significantly in recent months, it could move higher. A weaker pound has already had a positive impact on the index since the election. Looking ahead, a further depreciation could cause the index to move higher. Against this backdrop, buying large-cap shares could prove to be a shrewd move. Here are two stocks which have delivered stunning growth in the first half of the year, and could continue to do so over the medium term.

Resilient growth

Reporting on Wednesday was British American Tobacco (LSE: BATS). Its results for the first half of the year show it is making encouraging progress with its current strategy. Although volumes are expected to decline for the full year, they are set to be below the volume decline of the wider tobacco industry. The main reason for this is the strength of the company’s brands, and the customer loyalty which they enjoy. The Global Drive Brands have continued to deliver profit growth, although the company expects the bulk of profit growth to be weighted towards the second half of the year.

Looking ahead, British American Tobacco could become a more popular stock. The main reason for this is the resilient growth potential which it offers. Sales of tobacco products will not be affected by a change in government, nor will Brexit harm the company’s outlook. Therefore, its defensive qualities could cause investor sentiment to improve at a time when risks appear to be on the increase for UK investors.

Alongside this defensive business model is an improving growth outlook. The company’s investment into reduced risk products such as e-cigarettes may be hurting its cash flow, but it could provide a new avenue for growth over the medium term. While the company’s shares have already risen by 18% since the start of the year, more capital growth could lie ahead.

Growth potential

Also offering further upside potential after a strong first half of the year is speciality chemicals company Croda (LSE: CRDA). Its shares have risen by 24% since the start of the year, but do not yet appear to have fully factored-in the company’s growth potential.

For example, in the current year the business is expected to record a rise in its earnings of 28%. This is around four times the forecast growth rate of the FTSE 100, and yet Croda trades on a price-to-earnings growth (PEG) ratio of only 0.8. This suggests that it offers growth at a reasonable price. At a time when the FTSE 100 is trading at a record high, this could lead to improving investor sentiment.

In addition, Croda offers an improving income outlook. It may only yield 2.1% at the present time, but dividends are due to rise by 8.6% next year. This is well ahead of an inflation rate which could continue to rise. And with the company having a dividend coverage ratio of 2.1, further dividend growth could lie ahead over the medium term.

Peter Stephens owns shares of British American Tobacco. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »

Businessman hand stacking money coins with virtual percentage icons
Investing Articles

Here’s how investors can aim for £11,363 a year in passive income from £20,000 in this overlooked FTSE media gem

I think this media stock is commonly overlooked by investors looking for high passive income, but it shouldn’t be, given…

Read more »

Tesla car at super charger station
Investing Articles

Why is Tesla stock down 30% since late 2025?

Tesla stock has been a bit of a car crash in 2026. Edward Sheldon looks at what’s going on, and…

Read more »

UK supporters with flag
Investing Articles

Is Wise now the UK stock market’s top growth share?

Wise rose around 4% in the UK stock market yesterday, bringing its four-year gain to 135%. Why are investors warming…

Read more »

Warhammer World gathering
Investing Articles

£20,000 invested in this FTSE 100 stock 10 years ago is now worth this astonishing amount…

This FTSE 100 stock's delivered an amazing return over the past 10 years. James Beard considers whether it’s worth holding…

Read more »